Shire / NPS
Recovering from a botched deal with AbbVie Inc. last year, Irish drugmaker Shire plc said Jan. 12 it would purchase Bedminster, N.J.-based NPS Pharmaceuticals Inc. for $5.2 billion. Davis Polk & Wardwell, along with Slaughter and May, is representing Shire in the transaction, while Skadden, Arps, Slate, Meagher & Flom is legal counsel to NPS.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
